Humabs BioMed's Acquisition

Humabs BioMed was acquired by Vir Biotechnology on September 25, 2017.

Humabs BioMed is using its proprietary CellClone technologies to discover effective new treatments against a variety of viral and bacterial infections.…

Articles about Humabs BioMed's Acquisition: